Trials / Completed
CompletedNCT04946903
A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
A Randomized, Open Label, Single Dose, 2-way Crossover Clinical Trial to Evaluate the Pharmacokinetic Characteristics and Safety Between HCP1902 and RLD2007/RLD2008 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years – 54 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HCP1902 and co-administration of RLD2007/RLD2008 in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RLD2007 | Take it once per period. |
| DRUG | RLD2008 | Take it once per period. |
| DRUG | HCP1902 | Take it once per period. |
Timeline
- Start date
- 2021-06-10
- Primary completion
- 2021-08-10
- Completion
- 2021-08-10
- First posted
- 2021-07-01
- Last updated
- 2022-08-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04946903. Inclusion in this directory is not an endorsement.